Objective: The traditional approach to stable blunt thoracic aortic injury (BTAI) endorsed by the Society for Vascular Surgery is early (<24 hours) thoracic endovascular aortic repair (TEVAR). Recently, some studies have shown improved mortality in stable BTAI patients repaired in a delayed manner ($24 hours). However, the indications for use of delayed TEVAR for BTAI are not well characterized, and its overall impact on the patient's survival remains poorly understood. We sought to determine whether delayed TEVAR is associated with a decrease in mortality compared with early TEVAR in this population.
Whereas no randomized controlled trials exist, survival and major operative morbidity have improved significantly as thoracic endovascular aortic repair (TEVAR) for BTAI has largely supplanted open aortic repair (OAR) in most major trauma centers. [3] [4] [5] [6] Based on this evidence, in 2011 the Society for Vascular Surgery put forth guidelines endorsing early TEVAR as the preferred operative approach in BTAI patients, with delayed TEVAR (defined as repair after the first 24 hours of care) reserved for patients with prohibitive operative risk due to major associated injuries or severe comorbidities.
In recent years, however, a number of studies have suggested a mortality benefit in stable BTAI patients repaired in a delayed manner. 5, [7] [8] [9] [10] The latest multicenter trial published by the American Association for the Surgery of Trauma in 2008 showed an increase in the average time from admission to aortic repair from 15 to 55 hours compared with the original trial in 1997, and patients undergoing delayed repair had 65% lower mortality. 2, 4 Using this same population, Demetriades et al 5 showed a strong survival advantage with delayed repair in patients with and without severe associated injuries.
Other single-institution series also support improved survival and safety with delayed repair, specifically in patients with BTAI and traumatic brain injury (TBI), again with the conceptual underpinning for these findings being that delayed TEVAR allows stabilization and focused treatment of these associated injuries. 9, 10 Despite these findings, the indications for use of delayed TEVAR for BTAI are not well characterized, and its overall impact on the patient's survival remains poorly understood. To address these problems, we examined rates of early vs delayed TEVAR and associated mortality in BTAI patients across a 5-year period in a national sample of trauma patients. Our primary hypothesis was that delayed TEVAR would be associated with lower mortality than early TEVAR. We secondarily hypothesized that rates of early TEVAR would be higher than delayed TEVAR during the study period.
METHODS
This study was reviewed and approved by the University of Pennsylvania Institutional Review Board. Need for consent of the patient was waived because of the retrospective nature of the study design.
Population. We conducted a retrospective cohort study of adult patients using the National Trauma Data Bank National Sample Program (NSP) from 2009 to 2013. 11 The NSP is based on a nationally representative sample of the National Trauma Data Bank and contains data from 100 level I and level II trauma centers in the United States. Inclusion criteria for our study were age $18 years and BTAI as indicated by International Classification of Diseases, Ninth Revision (ICD-9) diagnosis code 901.0. Exclusion criteria for this study were age <18 years and injury mechanism other than blunt trauma. Patients with BTAI who underwent TEVAR were identified by ICD-9 procedure code 39.73. Patients with missing data on TEVAR timing (n ¼ 27) were excluded. Missing physiologic data was imputed using chained multiple imputation. 12 To describe the patients in the cohort, we first examined demographics, injury severity, presenting physiology, injury patterns, and procedures by repair type (none, OAR, or TEVAR) across the study period. To characterize injury patterns of patients in the cohort and procedures they underwent, we used ICD-9 diagnosis codes to define the following: rib fractures (807. Exposure and outcomes. The primary exposure of this study was the timing of TEVAR. Patients were grouped by the timing of TEVAR, with early TEVAR defined as repair <24 hours after injury and delayed TEVAR defined as repair $24 hours after injury, consistent with current nomenclature. The primary outcome measure was inhospital mortality. As secondary outcome measures, we examined rates of common complications recorded in the NSP data set (defined here as preoperative and postoperative complications occurring in $2% of the overall cohort), ventilator days, and intensive care unit (ICU) and hospital lengths of stay. We also examined rates of secondary aortic interventions (ICD-9 procedure codes 39.7 [3] [4] [5] [6] [7] [8] [9] ) and rates of subclavian revascularization (ICD-9 procedure code 39.22) between the early and delayed TEVAR groups. We additionally examined trends in incidence of early and delayed TEVAR across the study period. Finally, as an exploratory analysis, we examined the frequency of early TEVAR by trauma center for each of the centers contributing patients to the study.
Statistical analysis. We examined the association between TEVAR timing and in-hospital mortality using multivariable logistic regression models. Variables assessed for inclusion into multivariable mortality models included age, race, sex, motor component of the Glasgow Coma Scale (GCS) score on arrival, Injury Severity Score (ISS), admission systolic blood pressure, and admission heart rate. Variables associated with mortality significant at P # .2 in univariate analyses were included in multivariable logistic regression models using forced entry. Model discrimination and calibration for the final model were assessed using receiver operating characteristic curves and Hosmer-Lemeshow test, respectively. Differences in rates of complications between early and delayed TEVAR groups were assessed using the c 2 or Fisher exact test as appropriate, whereas differences in ventilator days and ICU and hospital lengths of stay between groups were assessed using the Kruskal-Wallis test. To evaluate temporal trends in incidence of early vs delayed repair in the TEVAR cohort during the study period, we used a variation of the Cochran-Armitage nonparametric tests of trend. Significance was defined as a P value <.05. All analyses were conducted using Stata (version 14.1; StataCorp LP, College Station, Tex).
ARTICLE HIGHLIGHTS

RESULTS
In total, 2045 adult patients presenting with BTAI were identified during the 5-year study period. Of these, 534 (26%) underwent TEVAR. Among the remaining 1511 BTAI patients who did not undergo TEVAR, 101 underwent OAR and 1410 underwent conservative management on their initial inpatient stay (Fig 1) . Twentyseven patients with missing data on timing of TEVAR were excluded, leaving a total of 507 patients for the primary analysis.
Characteristics of the patients. The characteristics of patients in the study by type of aortic repair can be seen in Table I . There were significant differences between patients who had no repair vs OAR vs TEVAR. Patients who had no repair tended to be older than patients undergoing OAR or TEVAR (median age, 47 years (interquartile range [IQR] , 31 years [61.0%]) vs 43 years (IQR, 28-59 years) vs 40.5 years (27-56 years), respectively; P < .001) and also had higher rates of specific injuries, most notably TBI (38.7% vs 31.7% in the OAR group vs 26.0% in the TEVAR group; P < .001). Conversely, rates of long bone fixation were lowest in the group that received no repair compared with the OAR group and the TEVAR group (11.9% vs 26.7% vs 32.8%, respectively; P < .001). Mortality was 20.9% for the no-intervention group, 25.7% for the OAR group, and 10.1% for the TEVAR group (P < .001). Demographic characteristics, injury severity, physiology, injury patterns, and procedural interventions of BTAI patients undergoing early vs delayed TEVAR are shown in Table II . Rates of missingness for physiologic data were low in the overall cohort and in the TEVAR group, ranging from 3.6% to 4%. Missingness was nondifferential between the early and delayed groups. Overall, the TEVAR cohort was 75% male and 69% white with a median age of 40 years (IQR, 27-56 years) and a median ISS of 34 (IQR, 26-41). Of these, 378 (74.6%) underwent early repair (<24 hours) and 129 (25.4%) underwent delayed repair ($24 hours). The median time to repair in the early TEVAR group was 5 hours (IQR, 4-11 hours) compared with 55 hours (IQR, 36-102 hours) in the delayed group. The two groups were similar with regard to age, sex, race, ISS, and presenting physiology. Rates of specific injuries and procedures were similar between the two groups with the exception of the rate of TBI, which was higher in the delayed group (38.8% vs 22.5%; P < .001).
In-hospital mortality. In patients undergoing TEVAR, 52 of 507 patients died, for an overall mortality of 10.3%. Observed mortality was 11.9% in the early TEVAR group vs 5.4% in the delayed group, for an unadjusted odds ratio of 2.36 (95% confidence interval [CI], 1.03-5.36; P ¼ .042) for the association between early TEVAR and mortality. Variables associated with mortality with P < .2 in univariate logistic regression analysis included age, ISS, GCS motor score, admission systolic blood pressure <90 mm Hg, and TBI. Although TBI was associated with mortality, because of concerns for collinearity with ISS and model parsimony, this variable was not included in our final multivariable model. After controlling for age, ISS, GCS motor score, and admission systolic blood pressure <90 mm Hg in multivariable logistic regression analysis, the association between early TEVAR and mortality was preserved (adjusted odds ratio, 2.39; 95% CI, 1.01-5.67; P ¼ .047; Table III Complications and resource use. Overall, the incidence of complications was 50% in patients undergoing TEVAR. The rate tended to be higher in the delayed vs early TEVAR group, but this did not reach statistical significance (47% vs 57%; P ¼ .07). In examining rates of specific complications, we found that rates of bleeding, decubitus ulcer, superficial surgical site infection, and pneumonia were significantly higher in the delayed group (Table IV) Rates of early and delayed TEVAR over time and by center. The incidence of early repair among BTAI patients undergoing TEVAR was 77.3% in 2009 and 71.1% in 2013. However, there was no significant trend across the study period (P ¼ .31; Fig 2) . The 509 TEVARs in our data set were performed at 71 trauma centers. Center volume ranged between 1 and 31 TEVARs per center; rates of early TEVAR ranged between 0% and 100% (Fig 3) .
DISCUSSION
In this study, we examined rates of early vs delayed TEVAR and associated mortality in BTAI patients across a 5-year period in a national sample of trauma patients. We found that the majority of BTAI patients undergoing TEVAR received an early repair and that the rate of early repair was stable throughout the study period. Furthermore, we showed that BTAI patients undergoing early repair had lower rates of bleeding, decubitus ulcer, superficial surgical site infection, and pneumonia as well as fewer hospital, ICU, and ventilator days. However, these patients still had a significantly higher odds of mortality compared with those undergoing delayed repair. These findings suggest that current practice guidelines be reviewed to reflect consideration of delayed TEVAR in a select subset of patients.
The current Society for Vascular Surgery guidelines endorse early TEVAR as the preferred operative approach in stable BTAI patients, with delayed TEVAR reserved for patients with major associated injuries or severe comorbidities. 3 In keeping with these recommendations, our study showed that the majority of BTAI patients undergoing TEVAR between the years 2009 and 2013 did so within 24 hours of admission. Our findings are consistent with data from other studies placing the percentage of patients with BTAI who undergo TEVAR between 4% and 65%. 10, [13] [14] [15] [16] [17] [18] We also demonstrate a continued role for conservative management in a subset of patients with BTAI as more than half of adult patients in our cohort were managed nonoperatively. Despite the prevalence of early TEVAR, several recent studies have shown that delayed TEVAR may be associated with improved survival in BTAI patients, even those without severe polytrauma. As evidenced by our findings, these studies have yet to inspire a national change to our standard of care for BTAI. There are several possible explanations for this. First, these studies do not characterize contemporary practice patterns with regard to timing of TEVAR across various trauma centers, which limits our ability to identify major obstacles to effecting widespread change in temporal management of BTAI. Furthermore, some of the earlier studies lack sufficient power to generate meaningful recommendations. Our project addresses these challenges by providing an improved understanding of how TEVAR for BTAI is approached nationwide and how time of repair affects mortality. Unlike other studies to date, we show that most BTAI patients undergoing TEVAR in this country still receive an early repair. We also show significantly reduced mortality with delayed TEVAR in this population. This important finding strengthens work presented in existing literature and calls into question our traditional understanding that BTAI requires early TEVAR. Our findings may suggest some flexibility in the timing of TEVAR for BTAI, which may help minimize conflicts in medical management and enable aortic repair under optimized circumstances.
Because of the design of our study, we are unable to definitively say what accounts for the difference in timing between the early and delayed TEVAR groups. Given the center-level variability in rates of early TEVAR, it is likely that center and provider factors play a role, but it is also probable that patient factors contribute. Although we did not see many differences in demographics of the patients, admission physiology, or injury severity between the early and delayed TEVAR groups, we did note that rates of TBI were higher in the delayed group. Because TEVAR is often performed under systemic anticoagulation, which is generally contraindicated in TBI, it is plausible that this could account for some of the delay between the groups, but definitive answers to this question will require prospective study.
Few studies have examined nonfatal outcomes in patients undergoing early vs delayed TEVAR in BTAI. The largest existing study in BTAI patients undergoing TEVAR (n ¼ 115) showed similar complication rates between early and delayed repair groups; however, delayed repair was associated with significantly longer ICU and hospital lengths of stay. 5 With our cohort, we reaffirmed that BTAI patients undergoing delayed TEVAR have longer ICU and hospital stays, but we also showed that delayed TEVAR patients have increased ventilator days and higher rates of bleeding, decubitus ulcer, superficial surgical site infection, and pneumonia. Thus, our study provides novel insight into the course of BTAI patients undergoing early vs delayed TEVAR. Whereas patients undergoing delayed TEVAR have improved mortality, they also experience higher rates of other potentially detrimental outcomes, suggesting a tradeoff function between death and complication rates with respect to the timing of TEVAR. The strengths of our study include the scope of information and sample size. Our study was designed to examine epidemiologic trends in timing of TEVAR for BTAI and associated outcomes. Use of the NSP data set allowed us to examine nationwide rates of early and delayed TEVAR for BTAI over time and to compare mortality rates across these two groups. Given the breadth of this nationally representative cohort, we believe that our findings are relevant for the management of most BTAI patients seen by level I and level II trauma centers across the United States. Importantly, BTAI is a rare injury, and many existing data sets do not have a sufficient sample size to generate meaningful findings. The large NSP data set, however, has untapped potential for studies on vascular trauma. This data set afforded us the largest BTAI population studied to date and enabled us to demonstrate a significant decrease in mortality with delayed TEVAR. We acknowledge several limitations to this work. Although use of the NSP allows a much larger sample size than has been achieved with previous single-center and multicenter studies, this data set records only information pertaining to the initial hospital stay after injury and does not include data beyond discharge. We are therefore unable to describe the long-term outcomes including mortality beyond the initial hospital admission. Other variables that may have been informative to explore between the early and delayed groups (such as transfusion requirements) are also not collected by the NSP. Although we are able to describe differences in rates of complications captured by the NSP between the early and delayed TEVAR groups, there are complications specific to TEVAR that are not captured by the NSP. As such, we are not able to describe rates of access site complications, paraplegia, paraparesis, or left subclavian artery coverage between the two groups. However, because the exposure of interest is the timing of TEVAR and not the technique itself, we have no a priori reason to suspect differential rates of these occurrences between the two groups. As is common in large trauma databases, data on admission physiology were missing at rates of up to 4%. However, we were able to partially mitigate the issue of bias introduced by case-wise deletion by imputing missing physiologic data using chained multiple imputation. Second, we do not have information on the grades of aortic injury of the patients in our study. These data are unfortunately not collected by the NSP, and as a result we were unable to control for injury grade in evaluating rates of early vs delayed repair and associated mortality. This is an important limitation of this study as aortic injury grade has been shown to predict overall mortality and aorta-related mortality in BTAI. 17, 19, 20 It is therefore possible that our findings reflect confounding by indication or the phenomenon in which higher grade injuries are associated with both our primary outcome of mortality and the exposure of early repair. 16 Whereas our data do not permit us to rule this out, prior studies have demonstrated improved survival with delayed repair even in BTAI patients with high-grade aortic injuries. 5, 21 One study even suggested that a subset of patients with grade 3 aortic injury can be safely managed nonoperatively. 22 In addition, adjusting for ISS in our multivariable model may have at least partially mitigated this issue, given that higher velocity injuries are associated with more multisystem trauma. 23 Finally, we are not able to distinguish cause-specific mortality in the NSP cohort, specifically mortality attributable to BTAI vs other causes. As a result, BTAI patients who suffer fatal aortic rupture before TEVAR are not captured in our cohort and thus are not accounted for in our mortality analysis comparing early vs delayed repair. Despite this potential limitation, numerous studies including the most recent American Association for the Surgery of Trauma multicenter study on BTAI demonstrate that the risk of inhospital aortic rupture while awaiting aortic repair is actually exceedingly low with appropriate blood pressure control. 14, 24, 25 Our study shows that most BTAI patients undergoing TEVAR from 2009 to 2013 received an early repair. However, delayed TEVAR was associated with reduced mortality in this population, even after adjustment for the degree of concomitant injuries. These findings support a need for critical reappraisal and clarification of existing practice guidelines in management of BTAI. A recent study has already proposed a new classification system and treatment strategy for BTAI, recommending that only Society for Vascular Surgery grade 4 injury (free aortic rupture) requires emergency TEVAR, whereas grade 3 injury (external contour abnormality or intimal tear >10 mm) can be managed with semielective TEVAR and grade 1 and grade 2 injury (external contour abnormality or intimal tear <10 mm) can be managed nonoperatively. 16 Future studies should seek to understand the decrease in mortality seen with delayed TEVAR and determine optimal selection of patients for early vs delayed repair. In addition, further examination of patient and institutional factors associated with early vs delayed TEVAR in BTAI will help improve our understanding of current practice patterns and identify potential barriers to optimal care, knowledge that is currently lacking and that promises to yield novel insights into how best to improve operative management of these injuries.
CONCLUSIONS
Consistent with current Society for Vascular Surgery recommendations, more BTAI patients underwent early TEVAR than delayed TEVAR during the study period. Patients undergoing delayed TEVAR had higher rates of specific complications and increased resource use but lower rates of risk-adjusted mortality. Existing practice guidelines in management of BTAI should be reappraised and clarified. Future studies should seek to understand the decrease in mortality seen with delayed TEVAR and determine optimal selection of patients for early vs delayed TEVAR. 
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